Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,069 | -89,056 | -56,617 | -31,938 | -17,085 |
| Depreciation Amortization | -506 | -846 | -249 | -97 | 9 |
| Accounts payable and accrued liabilities | -6,665 | 10,606 | 5,627 | 5,699 | 5,943 |
| Other Working Capital | 1,037 | 6,747 | -1,789 | -1,324 | 5,869 |
| Other Operating Activity | 9,911 | 4,953 | 6,594 | -354 | -3,717 |
| Operating Cash Flow | $-26,292 | $-67,596 | $-46,434 | $-28,014 | $-8,981 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -62 | -62 | -24 | -18 |
| Purchase Of Investment | -34,209 | -148,490 | -137,927 | -97,524 | -39,437 |
| Sale Of Investment | 46,443 | 78,000 | 54,000 | 15,999 | 0 |
| Investing Cash Flow | $12,234 | $-70,552 | $-83,989 | $-81,549 | $-39,455 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 19,816 | N/A | N/A | N/A |
| Common Stock Issued | 115,240 | 88,214 | 87,388 | 86,412 | 86,364 |
| Other Financing Activity | -7,256 | -6,097 | -6,164 | -6,096 | -6,096 |
| Financing Cash Flow | $107,984 | $101,933 | $81,224 | $80,316 | $80,268 |
| Beginning Cash Position | 43,752 | 79,967 | 79,967 | 79,967 | 79,967 |
| End Cash Position | 137,678 | 43,752 | 30,768 | 50,720 | 111,799 |
| Net Cash Flow | $93,926 | $-36,215 | $-49,199 | $-29,247 | $31,832 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,292 | -67,596 | -46,434 | -28,014 | -8,981 |
| Capital Expenditure | N/A | -62 | -62 | -24 | -18 |
| Free Cash Flow | -26,292 | -67,658 | -46,496 | -28,038 | -8,999 |